Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022

Upgrades

For Colliers International Group Inc CIGI, Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers Intl Gr earned $1.41 in the third quarter, compared to $1.27 in the year-ago quarter. The stock has a 52-week-high of $158.42 and a 52-week-low of $84.16. At the end of the last trading period, Colliers Intl Gr closed at $90.29.

According to Goldman Sachs, the prior rating for Gap Inc GPS was changed from Neutral to Buy. For the third quarter, Gap had an EPS of $0.71, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $19.06 and a 52-week-low of $7.79. Gap closed at $13.90 at the end of the last trading period.

According to Wolfe Research, the prior rating for Southern Co SO was changed from Peer Perform to Outperform. Southern earned $1.31 in the third quarter, compared to $1.23 in the year-ago quarter. The current stock performance of Southern shows a 52-week-high of $80.57 and a 52-week-low of $60.71. Moreover, at the end of the last trading period, the closing price was at $68.36.

For Tapestry Inc TPR, Goldman Sachs upgraded the previous rating of Neutral to Buy. For the first quarter, Tapestry had an EPS of $0.79, compared to year-ago quarter EPS of $0.82. The current stock performance of Tapestry shows a 52-week-high of $44.35 and a 52-week-low of $26.39. Moreover, at the end of the last trading period, the closing price was at $36.39.

According to Loop Capital, the prior rating for Acadia Healthcare Co Inc ACHC was changed from Hold to Buy. In the third quarter, Acadia Healthcare Co showed an EPS of $0.80, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $89.85 and a 52-week-low of $50.07. At the end of the last trading period, Acadia Healthcare Co closed at $82.25.

Citigroup upgraded the previous rating for Pulmonx Corp LUNG from Neutral to Buy. In the third quarter, Pulmonx showed an EPS of $0.38, compared to $0.28 from the year-ago quarter. The stock has a 52-week-high of $36.26 and a 52-week-low of $4.07. At the end of the last trading period, Pulmonx closed at $5.88.

According to Citigroup, the prior rating for Becton, Dickinson and Co BDX was changed from Sell to Neutral. For the fourth quarter, Becton, Dickinson had an EPS of $2.75, compared to year-ago quarter EPS of $2.15. The stock has a 52-week-high of $280.62 and a 52-week-low of $215.90. At the end of the last trading period, Becton, Dickinson closed at $247.60.

Citigroup upgraded the previous rating for Bio-Techne Corp TECH from Neutral to Buy. In the first quarter, Bio-Techne showed an EPS of $0.45, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $130.74 and a 52-week-low of $68.00. Bio-Techne closed at $80.73 at the end of the last trading period.

According to Citigroup, the prior rating for QuidelOrtho Corp QDEL was changed from Neutral to Buy. For the third quarter, QuidelOrtho had an EPS of $1.85, compared to year-ago quarter EPS of $5.36. At the moment, the stock has a 52-week-high of $180.06 and a 52-week-low of $66.88. QuidelOrtho closed at $92.30 at the end of the last trading period.

Deutsche Bank upgraded the previous rating for Lam Research Corp LRCX from Hold to Buy. In the first quarter, Lam Research showed an EPS of $10.42, compared to $8.36 from the year-ago quarter. The stock has a 52-week-high of $731.85 and a 52-week-low of $299.59. At the end of the last trading period, Lam Research closed at $450.20.

According to JP Morgan, the prior rating for Box Inc BOX was changed from Neutral to Overweight. For the third quarter, Box had an EPS of $0.31, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $33.04 and a 52-week-low of $22.31. Box closed at $28.11 at the end of the last trading period.

For CAE Inc CAE, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the second quarter, CAE had an EPS of $0.15, compared to year-ago quarter EPS of $0.14. The stock has a 52-week-high of $27.97 and a 52-week-low of $15.23. At the end of the last trading period, CAE closed at $20.37.

According to Morgan Stanley, the prior rating for Crane Co CR was changed from Equal-Weight to Overweight. Crane earned $1.86 in the third quarter, compared to $1.89 in the year-ago quarter. The current stock performance of Crane shows a 52-week-high of $114.87 and a 52-week-low of $82.14. Moreover, at the end of the last trading period, the closing price was at $99.56.

According to Morgan Stanley, the prior rating for Teledyne Technologies Inc TDY was changed from Underweight to Equal-Weight. Teledyne Technologies earned $4.54 in the third quarter, compared to $4.34 in the year-ago quarter. The stock has a 52-week-high of $493.97 and a 52-week-low of $325.00. At the end of the last trading period, Teledyne Technologies closed at $405.69.

Citigroup upgraded the previous rating for PerkinElmer Inc PKI from Neutral to Buy. PerkinElmer earned $1.51 in the third quarter, compared to $2.31 in the year-ago quarter. The current stock performance of PerkinElmer shows a 52-week-high of $203.16 and a 52-week-low of $113.46. Moreover, at the end of the last trading period, the closing price was at $139.15.

Stifel upgraded the previous rating for Under Armour Inc UAA from Hold to Buy. Under Armour earned $0.20 in the third quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.60 and a 52-week-low of $6.38. Under Armour closed at $9.53 at the end of the last trading period.

For Glaukos Corp GKOS, Citigroup upgraded the previous rating of Neutral to Buy. For the third quarter, Glaukos had an EPS of $0.45, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $64.49 and a 52-week-low of $33.33. At the end of the last trading period, Glaukos closed at $45.46.

According to Goldman Sachs, the prior rating for Best Buy Co Inc BBY was changed from Sell to Neutral. Best Buy Co earned $1.38 in the third quarter, compared to $2.08 in the year-ago quarter. The current stock performance of Best Buy Co shows a 52-week-high of $112.96 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $81.81.

For Monday.Com Ltd MNDY, JP Morgan upgraded the previous rating of Neutral to Overweight. For the third quarter, Monday.Com had an EPS of $0.05, compared to year-ago quarter EPS of $0.26. The current stock performance of Monday.Com shows a 52-week-high of $329.00 and a 52-week-low of $73.58. Moreover, at the end of the last trading period, the closing price was at $109.83.

See all analyst ratings upgrades.

Downgrades

For Levi Strauss & Co LEVI, Goldman Sachs downgraded the previous rating of Buy to Neutral. For the third quarter, Levi Strauss had an EPS of $0.40, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $26.06 and a 52-week-low of $13.57. Levi Strauss closed at $16.39 at the end of the last trading period.

For Newmark Group Inc NMRK, Goldman Sachs downgraded the previous rating of Neutral to Sell. For the third quarter, Newmark Group had an EPS of $0.35, compared to year-ago quarter EPS of $0.50. The current stock performance of Newmark Group shows a 52-week-high of $19.10 and a 52-week-low of $7.42. Moreover, at the end of the last trading period, the closing price was at $8.33.

According to Goldman Sachs, the prior rating for Ulta Beauty Inc ULTA was changed from Buy to Neutral. In the third quarter, Ulta Beauty showed an EPS of $5.34, compared to $3.94 from the year-ago quarter. The stock has a 52-week-high of $482.69 and a 52-week-low of $330.80. At the end of the last trading period, Ulta Beauty closed at $471.63.

For KLA Corp KLAC, Deutsche Bank downgraded the previous rating of Buy to Hold. KLA earned $7.06 in the first quarter, compared to $4.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $457.12 and a 52-week-low of $250.20. KLA closed at $393.41 at the end of the last trading period.

B of A Securities downgraded the previous rating for Rockwell Automation Inc ROK from Buy to Neutral. For the fourth quarter, Rockwell Automation had an EPS of $3.04, compared to year-ago quarter EPS of $2.33. The stock has a 52-week-high of $354.99 and a 52-week-low of $190.08. At the end of the last trading period, Rockwell Automation closed at $259.81.

For Vontier Corp VNT, B of A Securities downgraded the previous rating of Buy to Neutral. For the third quarter, Vontier had an EPS of $0.86, compared to year-ago quarter EPS of $0.80. At the moment, the stock has a 52-week-high of $31.79 and a 52-week-low of $16.55. Vontier closed at $19.08 at the end of the last trading period.

For Coterra Energy Inc CTRA, Truist Securities downgraded the previous rating of Buy to Hold. For the third quarter, Coterra Energy had an EPS of $1.42, compared to year-ago quarter EPS of $0.52. The current stock performance of Coterra Energy shows a 52-week-high of $36.55 and a 52-week-low of $18.39. Moreover, at the end of the last trading period, the closing price was at $24.48.

For PDC Energy Inc PDCE, Truist Securities downgraded the previous rating of Buy to Hold. In the third quarter, PDC Energy showed an EPS of $3.77, compared to $2.33 from the year-ago quarter. The current stock performance of PDC Energy shows a 52-week-high of $89.22 and a 52-week-low of $44.00. Moreover, at the end of the last trading period, the closing price was at $61.82.

Truist Securities downgraded the previous rating for Murphy Oil Corp MUR from Buy to Hold. In the third quarter, Murphy Oil showed an EPS of $1.84, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.28 and a 52-week-low of $23.50. Murphy Oil closed at $40.97 at the end of the last trading period.

According to Roth Capital, the prior rating for DraftKings Inc DKNG was changed from Buy to Neutral. For the third quarter, DraftKings had an EPS of $1.00, compared to year-ago quarter EPS of $1.35. The current stock performance of DraftKings shows a 52-week-high of $33.26 and a 52-week-low of $9.77. Moreover, at the end of the last trading period, the closing price was at $13.96.

According to Goldman Sachs, the prior rating for RH RH was changed from Neutral to Sell. In the third quarter, RH showed an EPS of $5.67, compared to $7.03 from the year-ago quarter. The stock has a 52-week-high of $658.51 and a 52-week-low of $207.37. At the end of the last trading period, RH closed at $274.48.

For Illumina Inc ILMN, Citigroup downgraded the previous rating of Neutral to Sell. In the third quarter, Illumina showed an EPS of $0.34, compared to $1.45 from the year-ago quarter. The stock has a 52-week-high of $428.00 and a 52-week-low of $173.45. At the end of the last trading period, Illumina closed at $205.62.

Citigroup downgraded the previous rating for Baxter International Inc BAX from Buy to Neutral. For the third quarter, Baxter Intl had an EPS of $0.82, compared to year-ago quarter EPS of $1.02. At the moment, the stock has a 52-week-high of $89.70 and a 52-week-low of $49.83. Baxter Intl closed at $52.38 at the end of the last trading period.

According to Citigroup, the prior rating for Laboratory Corp of America Holdings LH was changed from Buy to Neutral. Laboratory Corp earned $4.68 in the third quarter, compared to $6.82 in the year-ago quarter. At the moment, the stock has a 52-week-high of $317.17 and a 52-week-low of $200.32. Laboratory Corp closed at $233.56 at the end of the last trading period.

According to Wells Fargo, the prior rating for Nevro Corp NVRO was changed from Overweight to Equal-Weight. Nevro earned $0.59 in the third quarter, compared to $0.87 in the year-ago quarter. The stock has a 52-week-high of $95.63 and a 52-week-low of $34.70. At the end of the last trading period, Nevro closed at $42.12.

Wells Fargo downgraded the previous rating for RxSight Inc RXST from Overweight to Equal-Weight. RxSight earned $0.50 in the third quarter, compared to $0.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.99 and a 52-week-low of $8.80. RxSight closed at $13.36 at the end of the last trading period.

For Spire Inc SR, B of A Securities downgraded the previous rating of Neutral to Underperform. Spire earned $0.66 in the fourth quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $79.24 and a 52-week-low of $61.52. At the end of the last trading period, Spire closed at $67.70.

For Allogene Therapeutics Inc ALLO, B of A Securities downgraded the previous rating of Buy to Underperform. Allogene Therapeutics earned $0.58 in the third quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $18.94 and a 52-week-low of $6.42. At the end of the last trading period, Allogene Therapeutics closed at $8.76.

For Johnson Controls International PLC JCI, B of A Securities downgraded the previous rating of Buy to Neutral. Johnson Controls Intl earned $0.99 in the fourth quarter, compared to $0.88 in the year-ago quarter. The current stock performance of Johnson Controls Intl shows a 52-week-high of $81.77 and a 52-week-low of $45.52. Moreover, at the end of the last trading period, the closing price was at $65.77.

For Trane Technologies PLC TT, B of A Securities downgraded the previous rating of Neutral to Underperform. In the third quarter, Trane Technologies showed an EPS of $2.27, compared to $1.80 from the year-ago quarter. The stock has a 52-week-high of $204.23 and a 52-week-low of $120.64. At the end of the last trading period, Trane Technologies closed at $175.26.

According to Deutsche Bank, the prior rating for Micron Technology Inc MU was changed from Buy to Hold. For the fourth quarter, Micron Technology had an EPS of $1.45, compared to year-ago quarter EPS of $2.42. The current stock performance of Micron Technology shows a 52-week-high of $98.45 and a 52-week-low of $48.45. Moreover, at the end of the last trading period, the closing price was at $54.87.

Goldman Sachs downgraded the previous rating for Brinker International Inc EAT from Neutral to Sell. In the first quarter, Brinker International showed an EPS of $0.57, compared to $0.34 from the year-ago quarter. The current stock performance of Brinker International shows a 52-week-high of $44.03 and a 52-week-low of $21.47. Moreover, at the end of the last trading period, the closing price was at $35.25.

For Boyd Gaming Corp BYD, JMP Securities downgraded the previous rating of Market Outperform to Market Perform. Boyd Gaming earned $1.48 in the third quarter, compared to $1.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of $46.10. Boyd Gaming closed at $58.64 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Heico Corp HEI from Overweight to Equal-Weight. In the third quarter, Heico showed an EPS of $0.60, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $165.79 and a 52-week-low of $126.95. Heico closed at $157.03 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Curtiss-Wright Corp CW from Overweight to Equal-Weight. Curtiss-Wright earned $2.07 in the third quarter, compared to $1.88 in the year-ago quarter. The stock has a 52-week-high of $182.55 and a 52-week-low of $124.37. At the end of the last trading period, Curtiss-Wright closed at $169.75.

For Moog Inc MOG, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. In the fourth quarter, Moog showed an EPS of $1.36, compared to $1.25 from the year-ago quarter.

Piper Sandler downgraded the previous rating for Leggett & Platt Inc LEG from Neutral to Underweight. In the third quarter, Leggett & Platt showed an EPS of $0.66, compared to $0.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $43.63 and a 52-week-low of $30.28. Leggett & Platt closed at $35.21 at the end of the last trading period.

For ShockWave Medical Inc SWAV, Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. ShockWave Medical earned $0.92 in the third quarter, compared to $0.05 in the year-ago quarter. The current stock performance of ShockWave Medical shows a 52-week-high of $320.54 and a 52-week-low of $113.36. Moreover, at the end of the last trading period, the closing price was at $230.06.

For Qualcomm Inc QCOM, Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. Qualcomm earned $3.13 in the fourth quarter, compared to $2.55 in the year-ago quarter. The current stock performance of Qualcomm shows a 52-week-high of $193.58 and a 52-week-low of $101.93. Moreover, at the end of the last trading period, the closing price was at $119.05.

Goldman Sachs downgraded the previous rating for Genuine Parts Co GPC from Neutral to Sell. Genuine Parts earned $2.23 in the third quarter, compared to $1.88 in the year-ago quarter. At the moment, the stock has a 52-week-high of $187.72 and a 52-week-low of $115.63. Genuine Parts closed at $182.26 at the end of the last trading period.

For Cheesecake Factory Inc CAKE, Goldman Sachs downgraded the previous rating of Neutral to Sell. Cheesecake Factory earned $0.03 in the third quarter, compared to $0.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $44.65 and a 52-week-low of $26.05. Cheesecake Factory closed at $33.03 at the end of the last trading period.

According to Piper Sandler, the prior rating for OceanFirst Financial Corp OCFC was changed from Overweight to Neutral. For the third quarter, OceanFirst Financial had an EPS of $0.60, compared to year-ago quarter EPS of $0.45. The current stock performance of OceanFirst Financial shows a 52-week-high of $24.25 and a 52-week-low of $18.24. Moreover, at the end of the last trading period, the closing price was at $22.35.

Piper Sandler downgraded the previous rating for Accenture PLC ACN from Neutral to Underweight. In the fourth quarter, Accenture showed an EPS of $2.60, compared to $2.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $417.37 and a 52-week-low of $242.95. Accenture closed at $288.41 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With a Buy rating, Maxim Group initiated coverage on LuxUrban Hotels Inc LUXH. The price target seems to have been set at $5.00 for LuxUrban Hotels. LuxUrban Hotels earned $0.03 in the third quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $1.99 and a 52-week-low of $1.27. LuxUrban Hotels closed at $1.62 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on Coeptis Therapeutics Holdings Inc COEP. The price target seems to have been set at $6.00 for Coeptis Therapeutics. For the third quarter, Coeptis Therapeutics had an EPS of $0.06, compared to year-ago quarter EPS of $0.45.

Credit Suisse initiated coverage on Royal Gold Inc RGLD with a Neutral rating. The price target for Royal Gold is set to $120.00. In the third quarter, Royal Gold showed an EPS of $0.71, compared to $0.84 from the year-ago quarter. The current stock performance of Royal Gold shows a 52-week-high of $147.70 and a 52-week-low of $84.54. Moreover, at the end of the last trading period, the closing price was at $110.55.

With a Positive rating, Susquehanna initiated coverage on STMicroelectronics NV STM. The price target seems to have been set at $50.00 for STMicroelectronics. STMicroelectronics earned $1.16 in the third quarter, compared to $0.51 in the year-ago quarter. The stock has a 52-week-high of $51.52 and a 52-week-low of $28.35. At the end of the last trading period, STMicroelectronics closed at $38.24.

With a Buy rating, EF Hutton initiated coverage on Sunworks Inc SUNW. The price target seems to have been set at $5.00 for Sunworks. For the third quarter, Sunworks had an EPS of $0.16, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $5.11 and a 52-week-low of $1.23. At the end of the last trading period, Sunworks closed at $2.12.

Cowen & Co. initiated coverage on Xenon Pharmaceuticals Inc XENE with an Outperform rating. In the third quarter, Xenon Pharmaceuticals showed an EPS of $0.57, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $41.39 and a 52-week-low of $24.36. Xenon Pharmaceuticals closed at $36.20 at the end of the last trading period.

Cowen & Co. initiated coverage on Acrivon Therapeutics Inc ACRV with an Outperform rating. At the moment, the stock has a 52-week-high of $20.70 and a 52-week-low of $10.90. Acrivon Therapeutics closed at $12.50 at the end of the last trading period.

With a Hold rating, Jefferies initiated coverage on Kinsale Capital Group Inc KNSL. The price target seems to have been set at $295.00 for Kinsale Capital Gr. In the third quarter, Kinsale Capital Gr showed an EPS of $1.64, compared to $1.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $334.99 and a 52-week-low of $180.05. Kinsale Capital Gr closed at $284.47 at the end of the last trading period.

With a Hold rating, Jefferies initiated coverage on Palomar Holdings Inc PLMR. The price target seems to have been set at $55.00 for Palomar Hldgs. Palomar Hldgs earned $0.29 in the third quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $95.20 and a 52-week-low of $44.01. Palomar Hldgs closed at $51.88 at the end of the last trading period.

Susquehanna initiated coverage on Analog Devices Inc ADI with a Positive rating. The price target for Analog Devices is set to $205.00. In the fourth quarter, Analog Devices showed an EPS of $2.73, compared to $1.73 from the year-ago quarter. The stock has a 52-week-high of $187.66 and a 52-week-low of $133.48. At the end of the last trading period, Analog Devices closed at $168.68.

Susquehanna initiated coverage on Wolfspeed Inc WOLF with a Neutral rating. The price target for Wolfspeed is set to $90.00. For the first quarter, Wolfspeed had an EPS of $0.04, compared to year-ago quarter EPS of $0.21. The current stock performance of Wolfspeed shows a 52-week-high of $125.58 and a 52-week-low of $58.07. Moreover, at the end of the last trading period, the closing price was at $82.67.

Susquehanna initiated coverage on Ambarella Inc AMBA with a Positive rating. The price target for Ambarella is set to $90.00. Ambarella earned $0.24 in the third quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $221.89 and a 52-week-low of $49.02. At the end of the last trading period, Ambarella closed at $78.07.

With a Buy rating, Jefferies initiated coverage on Acrivon Therapeutics Inc ACRV. The price target seems to have been set at $17.00 for Acrivon Therapeutics. The current stock performance of Acrivon Therapeutics shows a 52-week-high of $20.70 and a 52-week-low of $10.90. Moreover, at the end of the last trading period, the closing price was at $12.50.

With a Buy rating, HC Wainwright & Co. initiated coverage on Affimed NV AFMD. The price target seems to have been set at $6.00 for Affimed. For the third quarter, Affimed had an EPS of $0.11, compared to year-ago quarter EPS of $0.14. The stock has a 52-week-high of $6.91 and a 52-week-low of $1.40. At the end of the last trading period, Affimed closed at $2.04.

Keybanc initiated coverage on Coinbase Global Inc COIN with a Sector Weight rating. Coinbase Global earned $2.43 in the third quarter, compared to $1.62 in the year-ago quarter. The current stock performance of Coinbase Global shows a 52-week-high of $284.99 and a 52-week-low of $40.15. Moreover, at the end of the last trading period, the closing price was at $40.24.

With an Overweight rating, Piper Sandler initiated coverage on X4 Pharmaceuticals Inc XFOR. The price target seems to have been set at $3.00 for X4 Pharmaceuticals. In the third quarter, X4 Pharmaceuticals showed an EPS of $0.26, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $4.20 and a 52-week-low of $0.86. At the end of the last trading period, X4 Pharmaceuticals closed at $0.93.

Piper Sandler initiated coverage on Acrivon Therapeutics Inc ACRV with an Overweight rating. The price target for Acrivon Therapeutics is set to $25.00. The current stock performance of Acrivon Therapeutics shows a 52-week-high of $20.70 and a 52-week-low of $10.90. Moreover, at the end of the last trading period, the closing price was at $12.50.

See all analyst ratings initiations.